Back

SMART2 recurrent CVD event risk for stratification of cumulative healthcare costs

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis as an inflammatory process (2) Cardiovascular Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Jonathan Ebbers

University Medical Center Utrecht, Utrecht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Epigenetic vs chronologic age for cardiovascular risk assessment
Doctor R. Ibrahim (Phoenix, US)
Abstract Slides Video
Presentation thumbnail
The additive prognostic value of C-reactive protein for all-cause and cardiovascular mortality across the PREVENT-defined cardiovascular risk continuum: a nationally representative cohort study
Doctor V. Jaiswal (Glenview, US)
Abstract Slides Video
Presentation thumbnail
Long-term cardiovascular risk following COVID-19 hospitalisation in a large US health system: temporal and prediction modelling
Doctor G. Fontana (Thousand Oaks, US)
Abstract Slides Video
Presentation thumbnail
Integrated clinical and polygenic coronary artery disease risk score predicts 10-year progression of coronary artery plaque
Mr B. Weijs (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Differential associations of cardiorenal-inflammatory markers with incident cardiovascular disease and cancer in the general population
Doctor Y. YANG (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis as an inflammatory process (2)

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease
3 April 2025
thumbnail
Congress Presentation
Healthcare related resource use and costs among patients with new diagnosis of Heart Failure in Germany: a retrospective cohort study using AOK PLUS data - part of the HF-BoI Project
29 June 2021
thumbnail
Congress Presentation
Cost-effectiveness of statin therapy in categories of patients in the UK
27 August 2022
thumbnail
Congress Presentation
Cardiovascular disease prevention: the economic imperative
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources